122 related articles for article (PubMed ID: 8371932)
1. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
5. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
6. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251
[TBL] [Abstract][Full Text] [Related]
7. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of age-associated macular degeneration with interferon-alfa-2a].
Thölen A; Kain H; Messmer E
Ophthalmologe; 1993 Jun; 90(3):279-82. PubMed ID: 8334332
[TBL] [Abstract][Full Text] [Related]
10. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study.
Lewis H; Kaiser PK; Lewis S; Estafanous M
Am J Ophthalmol; 1999 Aug; 128(2):135-46. PubMed ID: 10458168
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial.
Lewis H; VanderBrug Medendorp S
Ophthalmology; 1997 Nov; 104(11):1847-51; discussion 1852. PubMed ID: 9373115
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa-2a in the treatment of exudative age-related macular degeneration.
Lewis ML; Davis J; Chuang E
Graefes Arch Clin Exp Ophthalmol; 1993 Nov; 231(11):615-8. PubMed ID: 8258394
[TBL] [Abstract][Full Text] [Related]
14. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB
Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
[TBL] [Abstract][Full Text] [Related]
15. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
[TBL] [Abstract][Full Text] [Related]
16. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.
Reichel E; Berrocal AM; Ip M; Kroll AJ; Desai V; Duker JS; Puliafito CA
Ophthalmology; 1999 Oct; 106(10):1908-14. PubMed ID: 10519584
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Fujii GY; De Juan E; Humayun MS; Sunness JS; Chang TS; Rossi JV
Am J Ophthalmol; 2003 Dec; 136(6):1067-78. PubMed ID: 14644217
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of radiation for age-related macular degeneration.
Char DH; Irvine AI; Posner MD; Quivey J; Phillips TL; Kroll S
Am J Ophthalmol; 1999 May; 127(5):574-8. PubMed ID: 10334351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]